comprehensive -WSS

comprehensive

author：focus 2025-10-03 00:22:36 - browse：7676

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Testing for cancer recurrence creates a new limbo for patients

New safety details link Apellis eye drug to rare cases of blindness

Micronoma's microbiome cancer diagnostic approach under fire

5 important ways Henrietta Lacks changed medical science

What the airline industry can learn from medicine

knowledge

comprehensive

entertainment

What does generative AI mean for health care? We asked experts

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Alkermes shareholders re

‘Oppenheimer’ and the risks of AI in health care

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: New research from Sanofi, Regeneron, etc.

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mitch McConnell episode has important public health takeaway

BioMarin wins approval for gene therapy to treat hemophilia A

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

knowledge

Traditional Chinese medicine benefits explored in new JAMA study

Trump indictment: Who are the 'co

The FDA weighs the risks of candy

CDC recommends rationing of RSV shot due to shortages

Cassava reveals details — and problems — with Alzheimer's study

Sage hopes for a blockbuster in antidepressant now before FDA

hotspot

focus

entertainment

Wikipedia